These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Binding of Noradrenaline to Native and Intermediate States during the Fibrillation of α-Synuclein Leads to the Formation of Stable and Structured Cytotoxic Species. Singh P; Bhat R ACS Chem Neurosci; 2019 Jun; 10(6):2741-2755. PubMed ID: 30917654 [TBL] [Abstract][Full Text] [Related]
23. Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody. Colby DW; Chu Y; Cassady JP; Duennwald M; Zazulak H; Webster JM; Messer A; Lindquist S; Ingram VM; Wittrup KD Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17616-21. PubMed ID: 15598740 [TBL] [Abstract][Full Text] [Related]
24. The inhibitory effects of biomimetically designed peptides on α-synuclein aggregation. Rezaeian N; Shirvanizadeh N; Mohammadi S; Nikkhah M; Arab SS Arch Biochem Biophys; 2017 Nov; 634():96-106. PubMed ID: 28965745 [TBL] [Abstract][Full Text] [Related]
26. Single-chain Fv Antibodies for Targeting Neurodegenerative Diseases. Chia KY; Ng KY; Koh RY; Chye SM CNS Neurol Disord Drug Targets; 2018; 17(9):671-679. PubMed ID: 29546836 [TBL] [Abstract][Full Text] [Related]
27. ESCRT-mediated uptake and degradation of brain-targeted α-synuclein single chain antibody attenuates neuronal degeneration in vivo. Spencer B; Emadi S; Desplats P; Eleuteri S; Michael S; Kosberg K; Shen J; Rockenstein E; Patrick C; Adame A; Gonzalez T; Sierks M; Masliah E Mol Ther; 2014 Oct; 22(10):1753-67. PubMed ID: 25008355 [TBL] [Abstract][Full Text] [Related]
28. Intrabodies binding the proline-rich domains of mutant huntingtin increase its turnover and reduce neurotoxicity. Southwell AL; Khoshnan A; Dunn DE; Bugg CW; Lo DC; Patterson PH J Neurosci; 2008 Sep; 28(36):9013-20. PubMed ID: 18768695 [TBL] [Abstract][Full Text] [Related]
29. Sequestration of a β-hairpin for control of α-synuclein aggregation. Mirecka EA; Shaykhalishahi H; Gauhar A; Akgül Ş; Lecher J; Willbold D; Stoldt M; Hoyer W Angew Chem Int Ed Engl; 2014 Apr; 53(16):4227-30. PubMed ID: 24623599 [TBL] [Abstract][Full Text] [Related]
30. Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease. Lecerf JM; Shirley TL; Zhu Q; Kazantsev A; Amersdorfer P; Housman DE; Messer A; Huston JS Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4764-9. PubMed ID: 11296304 [TBL] [Abstract][Full Text] [Related]
31. Uncovering the Binding and Specificity of β-Wrapins for Amyloid-β and α-Synuclein. Orr AA; Wördehoff MM; Hoyer W; Tamamis P J Phys Chem B; 2016 Dec; 120(50):12781-12794. PubMed ID: 27934063 [TBL] [Abstract][Full Text] [Related]
32. Lipid metabolism alterations in the neuronal response to A53T α-synuclein and Fe-induced injury. Sánchez Campos S; Alza NP; Salvador GA Arch Biochem Biophys; 2018 Oct; 655():43-54. PubMed ID: 30098984 [TBL] [Abstract][Full Text] [Related]
34. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations. Sahay S; Ghosh D; Singh PK; Maji SK Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727 [TBL] [Abstract][Full Text] [Related]
35. Extending the functional characteristics of naturally occurring autoantibodies against β-Amyloid, Prion Protein and α-Synuclein. Albus A; Gold M; Bach JP; Burg-Roderfeld M; Jördens M; Kirchhein Y; Kronimus Y; Mengel D; Zerr I; Dodel R PLoS One; 2018; 13(8):e0202954. PubMed ID: 30157279 [TBL] [Abstract][Full Text] [Related]
36. Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein. Pavoni E; Flego M; Dupuis ML; Barca S; Petronzelli F; Anastasi AM; D'Alessio V; Pelliccia A; Vaccaro P; Monteriù G; Ascione A; De Santis R; Felici F; Cianfriglia M; Minenkova O BMC Cancer; 2006 Feb; 6():41. PubMed ID: 16504122 [TBL] [Abstract][Full Text] [Related]
37. Direct in vivo screening of intrabody libraries constructed on a highly stable single-chain framework. der Maur AA; Zahnd C; Fischer F; Spinelli S; Honegger A; Cambillau C; Escher D; Plückthun A; Barberis A J Biol Chem; 2002 Nov; 277(47):45075-85. PubMed ID: 12215438 [TBL] [Abstract][Full Text] [Related]
38. Human recombinant single-chain antibody fragments, specific for the hypervariable region 1 of hepatitis C virus, from immune phage-display libraries. Zhai W; Davies J; Shang DZ; Chan SW; Allain JP J Viral Hepat; 1999 Mar; 6(2):115-24. PubMed ID: 10607222 [TBL] [Abstract][Full Text] [Related]
39. Antibodies against alpha-synuclein: tools and therapies. Vaikath NN; Hmila I; Gupta V; Erskine D; Ingelsson M; El-Agnaf OMA J Neurochem; 2019 Sep; 150(5):612-625. PubMed ID: 31055836 [TBL] [Abstract][Full Text] [Related]
40. Comparison of α-Synuclein Fibril Inhibition by Four Different Amyloid Inhibitors. Jha NN; Kumar R; Panigrahi R; Navalkar A; Ghosh D; Sahay S; Mondal M; Kumar A; Maji SK ACS Chem Neurosci; 2017 Dec; 8(12):2722-2733. PubMed ID: 28872299 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]